Distant metastasis time to event analysis with CNNs in independent head and neck cancer cohorts.

Journal: Scientific reports
PMID:

Abstract

Deep learning models based on medical images play an increasingly important role for cancer outcome prediction. The standard approach involves usage of convolutional neural networks (CNNs) to automatically extract relevant features from the patient's image and perform a binary classification of the occurrence of a given clinical endpoint. In this work, a 2D-CNN and a 3D-CNN for the binary classification of distant metastasis (DM) occurrence in head and neck cancer patients were extended to perform time-to-event analysis. The newly built CNNs incorporate censoring information and output DM-free probability curves as a function of time for every patient. In total, 1037 patients were used to build and assess the performance of the time-to-event model. Training and validation was based on 294 patients also used in a previous benchmark classification study while for testing 743 patients from three independent cohorts were used. The best network could reproduce the good results from 3-fold cross validation [Harrell's concordance indices (HCIs) of 0.78, 0.74 and 0.80] in two out of three testing cohorts (HCIs of 0.88, 0.67 and 0.77). Additionally, the capability of the models for patient stratification into high and low-risk groups was investigated, the CNNs being able to significantly stratify all three testing cohorts. Results suggest that image-based deep learning models show good reliability for DM time-to-event analysis and could be used for treatment personalisation.

Authors

  • Elia Lombardo
    Department of Radiation Oncology, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Christopher Kurz
    Department of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München (LMU Munich), Garching bei München, 85748, Germany.
  • Sebastian Marschner
    Department of Radiation Oncology, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Michele Avanzo
    Division of Medical Physics, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081, Aviano, PN, Italy.
  • Vito Gagliardi
    Medical Physics Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081, Aviano, Italy.
  • Giuseppe Fanetti
    Radiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081, Aviano, Italy.
  • Giovanni Franchin
    Radiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081, Aviano, Italy.
  • Joseph Stancanello
    Division of Medical Physics, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081, Aviano, PN, Italy.
  • Stefanie Corradini
    Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
  • Maximilian Niyazi
    Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Claus Belka
    Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
  • Katia Parodi
    Department of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München (LMU Munich), Garching bei München, 85748, Germany.
  • Marco Riboldi
    Department of Medical Physics, Ludwig-Maximilians-Universität München, Germany.
  • Guillaume Landry
    Department of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München (LMU Munich), Garching bei München, 85748, Germany.